Proportions of ever-users who vaped/smoked in the past 30 days, past week, and on ≥20 days in the past month, by country, 2017–2019
Canada | England | USA | ||||||||||
2017 | 2018 | 2019 | Difference 2019 vs 2018 | 2017 | 2018 | 2019 | Difference 2019 vs 2018 | 2017 | 2018 | 2019 | Difference 2019 vs 2018 | |
Vaping
(among ever-vapers) | n=1182 | n=1275 | n=1680 | n=1348 | n=1283 | n=1260 | n=1283 | n=1336 | n=1734 | |||
Past 30-day vaping | 28.8% (340) | 36.3% (463) | 43.9% (738) | 1.36 (1.17 to 1.59); p<0.0001 | 25.8% (347) | 27.3% (351) | 34.8% (439) | 1.44 (1.19 to 1.75); p=0.0002 | 35.4% (454) | 47.5% (635) | 42.5% (736) | 0.81 (0.68 to 0.97); p=0.02 |
Past-week vaping | 17.6% (208) | 22.7% (290) | 30.2% (508) | 1.48 (1.24 to 1.75); p<0.0001 | 13.7% (184) | 14.0% (179) | 19.2% (241) | 1.49 (1.17 to 1.91); p=0.001 | 20.4% (262) | 31.1% (416) | 29.0% (503) | 0.91 (0.75 to 1.09); p=0.31 |
Vaping ≥20 days of past 30 | 6.3% (74) | 7.2% (92) | 14.0% (236) | 2.11 (1.63 to 2.73); p<0.0001 | 4.4% (59) | 5.9% (76) | 7.5% (94) | 1.33 (0.92 to 1.94); p=0.13 | 6.9% (89) | 11.5% (154) | 15.4% (267) | 1.42 (1.10 to 1.85); p=0.008 |
Cigarette smoking
(among ever-smokers) | n=1288 | n=1193 | n=1287 | n=1615 | n=1554 | n=1334 | n=1322 | n=1306 | n=1334 | |||
Past 30-day smoking | 33.4% (431) | 32.1% (383) | 29.8% (384) | 0.91 (0.77 to 1.07); p=0.24 | 38.5% (622) | 41.5% (645) | 38.9% (519) | 0.90 (0.76 to 1.06); p=0.19 | 34.1% (451) | 36.0% (470) | 23.6% (315) | 0.56 (0.46 to 0.67); p<0.0001 |
Past-week smoking | 23.9% (308) | 24.4% (291) | 22.4% (288) | 0.90 (0.76 to 1.07); p=0.23 | 24.2% (391) | 28.6% (444) | 26.7% (356) | 0.91 (0.76 to 1.09); p=0.29 | 26.3% (347) | 25.7% (336) | 17.3% (231) | 0.61 (0.50 to 0.76); p<0.0001 |
Smoking ≥20 days of past 30 | 13.4% (173) | 13.3% (158) | 9.2% (118) | 0.66 (0.53 to 0.83); p=0.0004 | 10.7% (173) | 14.5% (226) | 12.3% (165) | 0.83 (0.65 to 1.05); p=0.11 | 11.4% (151) | 11.9% (156) | 7.5% (100) | 0.61 (0.46 to 0.80); p=0.0004 |
Data are weighted %(n) or adjusted OR (AOR) with 95% CI and associated p values, adjusted for sex, age group and race/ethnicity.